MARKET

ITCI

Intra-Cellular Therapies
ITCI
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-37.7116
20.58
12.20
14,047,000,227.12
Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews
Benzinga · 04/02 22:01
*News On Intra-Cellular Therapies Inc. (ITCI) Now Under JNJ
Dow Jones · 04/02 21:08
Intra-Cellular Therapies Completes Merger with Johnson & Johnson
TipRanks · 04/02 20:30
Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended
Benzinga · 04/02 16:26
Intra-Cellular Therapies Price Target Maintained With a $132.00/Share by Cantor Fitzgerald
Dow Jones · 04/02 14:42
Cantor Fitzgerald Reiterates Neutral on Intra-Cellular Therapies, Maintains $132 Price Target
Benzinga · 04/02 14:32
Intra-Cellular Therapies (ITCI) Receives a Rating Update from a Top Analyst
TipRanks · 04/02 12:56
Johnson & Johnson Set To Complete Acquisition Of Intra-Cellular Therapies By April 2, 2025
NASDAQ · 04/02 02:33
More

Webull offers Intra-Cellular Therapies stock information, including NASDAQ: ITCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ITCI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ITCI stock methods without spending real money on the virtual paper trading platform.